MD1041C2 - Method for prognostication of middle ear latent diseases to children in the first year of life - Google Patents
Method for prognostication of middle ear latent diseases to children in the first year of lifeInfo
- Publication number
- MD1041C2 MD1041C2 MD97-0046A MD970046A MD1041C2 MD 1041 C2 MD1041 C2 MD 1041C2 MD 970046 A MD970046 A MD 970046A MD 1041 C2 MD1041 C2 MD 1041C2
- Authority
- MD
- Moldova
- Prior art keywords
- life
- children
- middle ear
- prognostication
- year
- Prior art date
Links
- 210000000959 ear middle Anatomy 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 abstract 3
- 208000002787 Pregnancy Complications Diseases 0.000 abstract 2
- 208000027866 inflammatory disease Diseases 0.000 abstract 2
- 208000012113 pregnancy disease Diseases 0.000 abstract 2
- 206010056254 Intrauterine infection Diseases 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000474 nursing effect Effects 0.000 abstract 1
- 230000035935 pregnancy Effects 0.000 abstract 1
- 230000000630 rising effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to medicine, and particularly, to the otolaryngology.Summary of the invention consists in that there are found out the data about children hypotrophy grade (HG), presence of the inflammatory diseases in the first month of life (ID), nursing character (NC), pregnancy complications (PC), gestation age in weeks (GA) and antibiotic therapy in the first month of life (A), intrauterine infection (II), after what there are calculated the coefficient F1 and F2 according to the formula:F1 = 4,92×GH - 0,58×AI + 3,21× CA + 0,76× CS + 8,05×VG + 0,81×A + 10,75×II - 176,04;F2 = 3,91×GH + 0,34×AI + 4,21×CA + 1,12× CS + 8,25×VG + 1,11×A + 9,88×II - 185,93and if F1 is less than F2 there are prognosticated the middle ear inflammatory diseases.The technical result consists in method trustworthiness rising.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MD97-0046A MD1041C2 (en) | 1997-02-13 | 1997-02-13 | Method for prognostication of middle ear latent diseases to children in the first year of life |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MD97-0046A MD1041C2 (en) | 1997-02-13 | 1997-02-13 | Method for prognostication of middle ear latent diseases to children in the first year of life |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MD1041C2 true MD1041C2 (en) | 1999-06-30 |
Family
ID=62129583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MD97-0046A MD1041C2 (en) | 1997-02-13 | 1997-02-13 | Method for prognostication of middle ear latent diseases to children in the first year of life |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1041C2 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3181G2 (en) * | 2005-10-24 | 2007-06-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method of prognosticating the risk of development of nosocomial septico-purulent infections |
| MD291Z (en) * | 2010-07-19 | 2011-07-31 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method for predicting the development of adverse effects in hearing aids |
| MD732Z (en) * | 2013-04-12 | 2014-09-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method for determining the maximum speech intelligibility index |
-
1997
- 1997-02-13 MD MD97-0046A patent/MD1041C2/en unknown
Non-Patent Citations (1)
| Title |
|---|
| Абабий И.И. Рецидивирующие воспалительные заболевания среднего уха и верхних дыхательных путей в раннем детском возрасте. Дисс. д.м.н., М., 1986 г., с. 8 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3181G2 (en) * | 2005-10-24 | 2007-06-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method of prognosticating the risk of development of nosocomial septico-purulent infections |
| MD291Z (en) * | 2010-07-19 | 2011-07-31 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method for predicting the development of adverse effects in hearing aids |
| MD732Z (en) * | 2013-04-12 | 2014-09-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method for determining the maximum speech intelligibility index |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9609063A (en) | Dinucleotides useful for the treatment of lung diseases | |
| GB9015910D0 (en) | Novel use | |
| NO942351D0 (en) | ||
| ES488120A1 (en) | 17-Alkylcarbonates of corticoids, process for their preparation and their use as medicines against dermatoses. | |
| AU2262988A (en) | Natural feeling condom | |
| ATE241328T1 (en) | MEDICAL IMPLANTS MADE OF STRETCHABLE CRYSTALLIZABLE ELASTOMERS AND METHOD FOR IMPLANTING SAME | |
| EP1511071A3 (en) | Xe preamorphising implantation | |
| FI923155A0 (en) | GELGUMMI FOER ICKE-SPROEDA GELER. | |
| NO930232D0 (en) | VARIETY AND MANUFACTURING METHOD | |
| FI853456A0 (en) | EXPEKTORANT. | |
| MD1041C2 (en) | Method for prognostication of middle ear latent diseases to children in the first year of life | |
| TW200505811A (en) | An Li2O-Al2O3-SiO2 crystallizable glass and manufacturing method thereof | |
| AU4579501A (en) | Modulating production of pneumococcal capsular polysaccharide | |
| DK0594743T3 (en) | Continuous cell line and vaccine against avian coccidia | |
| NO982989L (en) | Use of inhibitors of the cellular Na + / H + exchanger (NHE) for the manufacture of a medicament for respiratory stimulation | |
| CA2061167A1 (en) | Process for the purification of a highly glycolsylated protein | |
| IL113280A0 (en) | Method of treating auto-immune diseases using type one interferons | |
| AR240396A1 (en) | A METHOD TO MANUFACTURE BUFFERS AND A BUFFER PRODUCED BY SUCH METHOD. | |
| DK166343C (en) | IMPROVED PIROXICAM CONTAINING MEDICINE | |
| O'reilly | Sexual behaviour, perceptions of infertility and family planning in sub-Saharan Africa | |
| AU581216B2 (en) | Production of d-alpha-tocopherol from natural plant sources | |
| Shapiro et al. | Demethylchlortetracycline in Clinical Practice: Results of Mass Clinical Field Trials and Description of Electronic Data Processing Methods Used in Tabulation and Analysis | |
| CA2419887A1 (en) | Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids | |
| GB8722470D0 (en) | Production of anti-genic protein-hapten conjugates | |
| UA26940C2 (en) | The mean for determiantion of a suppressor link of human immune status and the method for determination of a suppressor link of human immune status |